Zobrazeno 1 - 10
of 243
pro vyhledávání: '"Toru, Kubo"'
Autor:
Yuri Ochi, Naohito Yamasaki, Toru Kubo, Yuichi Baba, Kazuya Miyagawa, Tatsuya Noguchi, Takayoshi Hirota, Tomoyuki Hamada, Hiroaki Kitaoka
Publikováno v:
ESC Heart Failure, Vol 11, Iss 6, Pp 4000-4008 (2024)
Abstract Aims A fourth heart sound (S4) was reported to be almost never present in patients with amyloid light‐chain cardiomyopathy. There have been no reports on S4 in patients with wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM). T
Externí odkaz:
https://doaj.org/article/b197757cbdf4443e9d91f1a6c0f7941a
Autor:
Yuichi Baba, Yuri Ochi, Juri Kawaguchi, Azumi Takiishi, Daigo Hirakawa, Toru Kubo, Naohito Yamasaki, Hiroaki Kitaoka
Publikováno v:
Cardiovascular Ultrasound, Vol 22, Iss 1, Pp 1-6 (2024)
Abstract Background Echocardiography remains the reference-standard imaging technique for assessing valvular heart disease (VHD), but artifacts like the ‘color Doppler stripe’ can complicate diagnosis. This artifact is not widely recognized and c
Externí odkaz:
https://doaj.org/article/b5f3f93e145547279d8dc58a9359a2ea
Autor:
Tomoyuki Hamada, Toru Kubo, Kazuya Kawai, Yoko Nakaoka, Toshikazu Yabe, Takashi Furuno, Eisuke Yamada, Hiroaki Kitaoka, Kochi YOSACOI study
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2076-2085 (2024)
Abstract Aims This study aimed to evaluate the impact of frailty and living function domains based on the Kihon Checklist (KCL), a questionnaire for a comprehensive frailty assessment, on prognosis in patients with acute heart failure (AHF). Methods
Externí odkaz:
https://doaj.org/article/4c193c889b2640d8879ab4b0a0722a9e
Autor:
Kei Kawada, Tomoaki Ishida, Hitoshi Fukuda, Yuki Hyohdoh, Toru Kubo, Tomoyuki Hamada, Yuichi Baba, Toshinobu Hayashi, Fuka Aizawa, Kenta Yagi, Yuki Izawa-Ishizawa, Takahiro Niimura, Shinji Abe, Mitsuhiro Goda, Hiroaki Kitaoka, Keisuke Ishizawa
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
IntroductionGuideline-directed medical therapy with renin-angiotensin system (RAS) inhibitors and beta-blockers has improved the survival of patients with heart failure (HF) and reduced left ventricular ejection fraction (HFrEF). However, it is uncle
Externí odkaz:
https://doaj.org/article/e34bac9ce74848e2895ccbfef15b579c
Autor:
Tomoyuki Hamada, Toru Kubo, Kazuya Kawai, Yoko Nakaoka, Toshikazu Yabe, Takashi Furuno, Eisuke Yamada, Hiroaki Kitaoka, Kochi YOSACOI study
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 223-233 (2023)
Abstract Aims Guideline‐directed medical therapy (GDMT) in patients with heart failure with reduced ejection fraction (HFrEF) is recommended in clinical guidelines, but elderly patients have not fully received GDMT in the clinical situation. The ai
Externí odkaz:
https://doaj.org/article/133733bf5af747f481016cb2f0ebcebf
Autor:
Kenta Sugiura, Toru Kubo, Yuri Ochi, Kazuya Miyagawa, Yuichi Baba, Tatsuya Noguchi, Takayoshi Hirota, Naohito Yamasaki, Yoshinori L. Doi, Hiroaki Kitaoka
Publikováno v:
ESC Heart Failure, Vol 9, Iss 4, Pp 2618-2625 (2022)
Abstract Aims We aim to clarify the prognosis on patients with hypertrophic cardiomyopathy (HCM) for a follow‐up period of more than 10 years. Methods and results We retrospectively analysed 102 consecutive patients with HCM diagnosed by 31 Decembe
Externí odkaz:
https://doaj.org/article/717c54cba80a4f55857fe6373b35acf1
Autor:
Tomoyuki Hamada, Toru Kubo, Kazuya Kawai, Yoko Nakaoka, Toshikazu Yabe, Takashi Furuno, Eisuke Yamada, Hiroaki Kitaoka, Kochi YOSACOI study
Publikováno v:
ESC Heart Failure, Vol 9, Iss 3, Pp 1853-1863 (2022)
Abstract Aims The aim of this study was to elucidate the clinical characteristics, including frailty status, of patients with heart failure with preserved ejection fraction (HFpEF) in comparison with those in patients with heart failure with reduced
Externí odkaz:
https://doaj.org/article/cd30c1e3b4ec42b3b40a0dd3c1facb7a
Autor:
Nobuhiro Tahara, Olivier Lairez, Jin Endo, Atsushi Okada, Mitsuharu Ueda, Tomonori Ishii, Yoshinobu Kitano, Hahn‐Ey Lee, Eleonora Russo, Toru Kubo
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 251-262 (2022)
Abstract Transthyretin amyloid cardiomyopathy (ATTR‐CM) is caused by the cardiac deposition of insoluble amyloid fibrils formed by misfolded transthyretin proteins and is associated with various cardiac symptoms, such as progressive heart failure,
Externí odkaz:
https://doaj.org/article/98cc813d072b4159b66ec3db8e04be61
Autor:
Toru Kubo, Yuichi Baba, Yuri Ochi, Takayoshi Hirota, Naohito Yamasaki, Kazuya Kawai, Katsuhito Yamamoto, Fumiaki Kondo, Kanji Bando, Eisuke Yamada, Takashi Furuno, Toshikazu Yabe, Yoshinori L. Doi, Hiroaki Kitaoka
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 5022-5030 (2021)
Abstract Aims There is limited information about the clinical significance of atrial fibrillation (AF), particularly new‐onset AF, in patients with hypertrophic cardiomyopathy (HCM) in a community‐based patient cohort. This study was carried out
Externí odkaz:
https://doaj.org/article/1c4b510648f84e658f0bdb2278c7577d
Autor:
Tomoyuki Hamada, Toru Kubo, Kazuya Kawai, Yoko Nakaoka, Toshikazu Yabe, Takashi Furuno, Eisuke Yamada, Hiroaki Kitaoka, the Kochi YOSACOI study
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2876-2888 (2021)
Abstract Aims The aim of this study was to investigate clinical characteristics of frail patients based on a comprehensive frailty assessment in patients hospitalized for acute decompensated heart failure (HF) (ADHF) in super‐aged regional Japanese
Externí odkaz:
https://doaj.org/article/5fd9a69afc644b118bd293b203d6260e